Luo ilmainen tili jotta voit seurata yrityksiä, osallistua foorumin keskusteluun sekä kommentoida meidän sisältöä. Valitse sinulle sopivin tili.
Oliko sinulla jo tili?
Follow this company like 1253 other investors.
Carasent reported a stable quarter with good customer intake and clear signs of scalability. Given Carasent's cash position, we expect, not unsurprisingly, further M&A in the near term.
Carasent's net sales were in line with Redeye's estimates, but profitability and customer intake were stronger than expected. Redeye's first impression of Carasent's Q2'21 is positive, and the business shows good progress in almost every corner.
Yesterday, Vitruvian Partners invested NOK 420m in a private placement, making the private equity firm Carasent’s largest shareholder. We give our view on the news.
Yesterday, Carasent announced the acquisition of the Swedish company Metodika, as well as a private placement of almost NOK 370m in gross proceeds. Redeye’s comment follows.
Redeye comments on the news that the Stockholm regional council has decided to pursue a modular approach instead of procuring one big system for the whole region.
Redeye increases the near-term estimates slightly, thanks to the strong customer intake.
This is a short comment on the Q1 report. We will be back with a longer research note later.